Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term surgical adjuvant breast. Found 17 abstracts

Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz MP, Goldstein LJ, Isakoff SJ, Lyons J, Kelly Marcom P, Mayer IA, McCormick B, Moran MS, O'Regan RM, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Sitapati A, Smith KL, Smith ML, Soliman H, Somlo G, Telli M, Ward JH, Shead DA, Kumar R. NCCN Guidelines Insights: Breast Cancer, Version 1.2017. J Natl Compr Canc Netw. 2017 Apr;15(4):433-51.
Kaufmann M, von Minckwitz G, Mamounas EP, Cameron D, Carey LA, Cristofanilli M, Denkert C, Eiermann W, Gnant M, Harris JR, Karn T, Liedtke C, Mauri D, Rouzier R, Ruckhaeberle E, Semiglazov V, Symmans WF, Tutt A, Pusztai L. Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer. Annals of Surgical Oncology. 2012 May;19(5):1508-16.   PMCID: not NIH funded
Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Loftus L, MacDonald DJ, Mahoney MC, Merajver SD, Meszoely I, Newman L, Pritchard E, Seewaldt V, Sellin RV, Shapiro CL, Ward JH. Breast Cancer Risk Reduction. Journal of the National Comprehensive Cancer Network. 2010 Oct;8(10):1112-46.   PMCID: not NIH funded
Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Ljung BM, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Smith ML, Som G, Topham NS, Ward JH, Winer EP, Wolff AC. Breast Cancer: Noninvasive and Special Situations. Journal of the National Comprehensive Cancer Network. 2010 Oct;8(10):1182-207.   PMCID: not NIH funded
Freedman GM, Li TY, Anderson PR, Nicolaou N, Konski A. Health states of women after conservative surgery and radiation for breast cancer. Breast Cancer Research and Treatment. 2010 Jun;121(2):519-26.   PMCID: PMCID: PMC2874617 [Available on 2011/6/1]
Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, DiPetrillo T, Khan D, Hudes R. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. AMERICAN JOURNAL OF SURGERY. 2006 Oct;192(4):427-33.
Jordan VC. Improvements in tumor targeting, survivorship, and chemoprevention pioneered by tamoxifen - A personal perspective. ONCOLOGY-NEW YORK. 2006 May;20(6):553-62.
Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Siegfried JM, Evans AA, Blot WJ, Chow WH, Blount PL, Maley CC, Wang KK, Lam S, Lee JJ, Dubinett SM, Engstrom PF, Meyskens FL, O'Shaughnessy J, Hawk ET, Levin B, Nelson WG, Hong WK. Progress in chemoprevention drug development: The promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer - A plan to move forward. CLINICAL CANCER RESEARCH. 2006 Jun;12(12):3661-97.
Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER, Wade JL, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark NG. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2006 Jun;295(23):2727-41.
Davidson NE, Morrow M. Sometimes a great notion - An assessment of neoadjuvant systemic therapy for breast cancer. Journal of the National Cancer Institute. 2005 Feb 02;97(3):159-61.
Katz SJ, Lantz PM, Janz NK, Fagerlin A, Schwartz K, Liu LH, Deapen D, Salem B, Lakhani I, Morrow M. Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. Journal of Clinical Oncology. 2005 May;23(13):3001-7.
Osipo C, Meeke K, Liu H, Cheng D, Lim S, Weichel A, Jordan VC. Trastuzumab therapy for tamoxifen-stimulated endometrial cancer. Cancer Research. 2005 Sep 15;65(18):8504-13.
Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. The oncologist. 2004 Jan;9 (6):606-16.
McCaskill-Stevens W, Wilson J, Bryant J, Mamounas E, Garvey L, James J, Cronin W, Wickerham DL. Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifen. Journal of the National Cancer Institute. 2004 Dec;96(23):1762-9.
Fowble B, Yeh IT, Schultz DJ, Solin LJ, Rosato EF, Jardines L, Hoffman J, Eisenberg B, Weiss MC, Hanks G. The Role of Mastectomy in Patients with Stage I-Ii Breast- Cancer Presenting with Gross Multifocal or Multicentric Disease or Diffuse Microcalcifications. International Journal of Radiation Oncology Biology Physics. 1993 Oct 20;27(3):567-73.
Abe O, Abe R, Asaishi K, Enomoto K, Hattori T, Ino Y, Kikuchi K, Koyama H, Sawa K, Uchino J, Yoshida M, Haybittle JL, Vandevelde T, Vermorken JB, Harvey VJ, Holdaway TM, Kay RG, Mason BH, Forbes JF, Bastert G, Sauerbrei W, Scheurlen H, Schumacher M, Focan C, Lobelle JP, Peek U, Oates GD, Powell J, Durand M, Mauriac L, Gelman RS, Henderson IC, Shapiro CL, Hancock AK, Jackson S, Ragaz J, Korzun A, Wood WC, Yoshimoto M, Baum M, Houghton J, Horgan K, Hughes L, Stewart HJ, Gordon NH, Davis HL, Delozier T, Macelesech J, Rambert P, Andrysek O, Barkmanova J, Owen JR, Howell A, Ribeiro GC, Swindell R, Deoliveira CF, Carstensen B, Palshof T, Johansen H, Korzeniowski S, Skolyszewski J, Andersen KW, Dombernowsky P, Mouridsen HT, Rose C, Corcoran N, Trampisch HJ, Abeloff MD, Carbone PC, Glick J, Gray R, Tormey DC, Buyse M, Mignolet F, Paridaens R, Vandriel OJ, Sylvester RJ, Vandevelde CJ, Vandongen JA, Welvaart K, Scanlon EF, Schurman S, Catalano R, Creech RH, Deschryver A, McGregor K, Yosef HM, McArdle CS, Smith DC, Lara PC, Dent DM, Gudgeon CA, Hacking A, Boccardo F, Izuo M, Bentley A, Doran Z, Fentiman IS, Hayward JL, Rubens RD, Kaufmann M, Jonat W, Vonfournier D, Klefstrom P, Cuzick J, Margreiter R, Asselain B, Pouillard P, Bahi J, Milla A, Sanchiz F, Castiglione M, Cavalli F, Collins J, Gelber RD, Goldhirsch A, Isley MR, Lindtner J, Price KN, Rudenstam CM, Senn HJ, Bliss JM, Chilvers CE, Coombes RC, Marty M, Borovik R, Brufman G, Robinson E, Pannuti F, Takashima S, Yasutomi T, Holm LE, Sonoo H, Yamashita J, Bonte J, Buzdar AU, Smith T, Martin P, Romain S, Ahmann D, Schaid DJ, Hakes T, Norton L, Wittes R, Foroglou P, Lissaios B, Bonadonna G, Delvecchio M, Valagussa P, Veronesi U, Dubois JB, Hayat H, Bianco AR, Lippman ME, Pierce LJ, Simon R, Steinberg SM, Nomura Y, Delahuerta R, Sainz MG, Brown A, Fisher B, Redmond C, Wolmark N, Jackson IM, Palmer MK, Ingle JN, Bengtsson NO, Larsson LG, Lythgoe JP, Kissin M, Blamey RW, Mitchell AK, Robertson JF, Fluckiger H, Nakamura Y, Mathe G, Misset JL, Deshpande N, Dimartino L, Clarke EA, McLaughlin JR, Clark RM, Levine M, Morimoto K, Gundersen S, Hauerjensen M, Host H, Crossley E, Durrant K, Harris A, Clarke M, Collins R, Godwin J, Greaves E, Harwood C, Mead G, Peto R, Wheatley K, Hill C, Lacour J, Laplanche A, Le M, Sarrazin D, Semiglazov V, Brockschmidt J, Cooper MR, Meakin JW, Panzarella T, Pritchard KI, Treurnietdonker AD, Vanputten WL, Easton D, Powles TJ, Gazet JC, Douglas P, Lindtner A, Notter G, Bryant AJ, Ewing GH, Krushen JL, Nissenmeyer R, Forrest AP, McDonald C, Moller TR, Ryden S, Carstensen J, Hatschek T, Soderberg M, Carpenter JT, Crawley J, Green S, Osborne CK, Rutqvist LE, Wallgren A, Brenner H, Hercbergs A, Deboer G, Paterson AH, Naja A, Reid M, Spittle M, Senanayake F, Meier P, Tengrup I, Tennvallnittby L, Caffier H, Bezwoda WR, Holmberg L, Sevelda P, Zielinsky CC, Jakesz R, Buchanan RB, Cross M, Dunn JA, Gillespie, Kelly K, Morrison JM, Litton A, Chlebowski RT. Systemic Treatment of Early Breast-Cancer by Hormonal, Cytotoxic, or Immune Therapy - 133 Randomized Trials Involving 31000 Recurrences and 24000 Deaths among 75000 Women .2. Lancet (London, England). 1992 Jan 11;339(8785):71-85.
Pierce L, Fowble B, Solin LJ, Schultz DJ, Rosser C, Goodman RL. Conservative Surgery and Radiation-Therapy in Black-Women with Early Stage Breast-Cancer - Patterns of Failure and Analysis of Outcome. Cancer. 1992 Jun;69(11):2831-41.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term surgical adjuvant breast

surgical adjuvant breast mastectomy randomized-trial carcinoma breast cancer randomized controlled-trial cancer radiation-therapy postmenopausal women therapy endocrine therapy Oncology conserving surgery breast carcinoma tumors tamoxifen NCCN Guidelines NCCN Clinical Practice Guidelines survival 20-year follow-up athymic mice recurrence breast-conserving therapy bone-mineral density bowel project p-1 preoperative chemotherapy radiotherapy local recurrence index cell lung-cancer bilateral prophylactic mastectomy lymph-node dissection prevention trials menopausal 1st primary irradiation lymph-node metastases c-erbb-2 expression chemotherapy definitive irradiation fatigue update estrogen-receptor modulation states mammary-carcinoma raloxifene pathological findings sp1 phosphorylation Brachytherapy LCIS lobular carcinoma in situ conservative surgery italian randomized-trial her-2 accuracy prevention conserving therapy gross multicentric disease tamoxifen therapy carcinoma in-situ phase-iii college randomized trial upper-aerodigestive-tract american-joint-committee risk reduction reducing salpingo-oophorectomy growth-factor-receptor lumpectomy diffuse dietary modification trial placebo-controlled trial lumpectomy plus tamoxifen patient adjuvant therapy microcalcifications surrogate end-points endometrial carcinoma BCRA1 estrogen-receptor modulators phyllodes gene-transcription neu oncogene united-states hormone-replacement therapy population fulvestrant 500 mg outcomes high-grade dysplasia cyclophosphamide chemotherapy standard axillary treatment white women s-phase fraction multiple outcomes chronic hepatitis-c anastrozole 1 mg randomized-trials noninvasive breast predictive factors health survey sf-36 nuys prognostic young age expert panel experience estrogen-receptor status prophylactic mastectomy pagets-disease guideline cost ductal carcinoma in situ long-term tamoxifen median follow-up Surgery tumor estrogen-plus-progestin risk-factors epidemiology design activator inhibitor type-1 estrogen-receptor tumor growth stage-i requiring prolonged observation risk assessment radiation therapy surgery partial breast irradiation early breast-cancer prognostic factors conserving quality-of-life individual patient data phase II clinical trial Radiation therapy Breast cancer-EQ-5D-EuroQol-Health states intraductal-carcinoma mammary-carcinoma model hot flashes pathological complete response kinase pathway term-follow-up trends american-college clinical-oncology first-line therapy carcinoma in situ united- brca2 mutation carriers trial BCRA2 dna-adducts
Last updated on Thursday, April 02, 2020